HIF hydroxylation and the mammalian oxygen-sensing pathway
Open accessThe DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Hypoxia refers to below-normal levels of oxygen in air, blood, or tissue.Tissue hypoxia leads to cellular dysfunction and ultimately can lead to cell death.Causes of tissue hypoxia include (a) decreased blood oxygenation (such as occurs in certain pulmonary disorders), (b) altered oxygen release from hemoglobin (associated with some hemoglobinopathies), and (c) impaired blood delivery leading to localized anemia (i.e., ischemia) as a result of low cardiac output or vascular obstruction.In order to adapt to hypoxia, mammals use a number of physiological responses.These include (a) increased production of erythropoietin (EPO), which augments the production of red blood cells; (b) induction of tyrosine hydroxylase, which facilitates the control of ventilation through the carotid body; and (c) the stimulation of new blood vessels by upregulation of VEGF (1).At the cellular level, hypoxia induces a number of metabolic changes that allow for continued energy generation despite decreased oxygen availability. Hypoxia-inducible factorOne of the most important factors in the cellular response to hypoxia is hypoxia-inducible factor (HIF), which transcriptionally activates genes encoding proteins that mediate adaptive responses to reduced oxygen availability.HIF is a heterodimer consisting of one of three α subunits (HIF1-α, HIF2-α, or HIF3-α) bound to the aryl hydrocarbon receptor nuclear translocator (ARNT), which is also known as HIF1-β.HIF-α is a member of the basic helix-loop-helix (bHLH) superfamily, in which the HLH domain mediates sub-unit dimerization while the basic domain binds to DNA.HIF-α, like some other bHLH family members, contains a Per/Arnt/Sim (PAS) domain that facilitates the heterodimerization of HIF-α with ARNT (2-4).HIF target genes play critical roles in metabolism, angiogenesis, cell proliferation, and cell survival.Examples of HIF target genes include VEGF, glucose transporter 1 (GLUT1), and EPO.HIF binds to the hypoxia-responsive element, which contains the core recognition sequence 5′-TACGTG-3′ (5), in the cis-regulatory regions of hypoxia-inducible genes.Transcriptional activation by HIF is linked to its ability to recruit coactivator proteins such as CREB-binding protein (CBP), p300, steroid receptor coactivator-1, and translation initiation factor 2 (6-8).Whereas changes in oxygen levels do not affect ARNT protein levels, hypoxia markedly increases the abundance of the HIF-α subunits (9-11).This increase is due primarily to protein stabilization.In some settings, hypoxia also leads to increased HIF1-α mRNA accumulation (12,13).von Hippel-Lindau disease von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome that affects approximately 1 in 35,000 individuals.The syndrome was first described in 1894 by Collins, who observed two siblings with bilateral retinal angiomas (now also called hemangioblastomas) (14).Later, the disease was mapped to chromosome 3p25 (15), and the VHL gene itself was isolated in 1993 (16).VHL behaves as a classical tumor suppressor gene.Almost all individuals with a clinical diagnosis of VHL disease can be shown to harbor a germline mutation of the VHL gene, with tumor development linked to somatic inactivation or loss of the remaining wild-type allele (17).The cardinal features of VHL disease are blood vessel tumors of the retina and central nervous system.Other tumors associated with VHL disease include clear cell carcinomas of the kidney, pheochromocytoma, endolymphatic sac tumors, pancreatic islet cell tumors, and papillary cystadenomas of the epididymis (in males) or broad ligament (in females) (18).In addition, patients with VHL often develop multiple visceral cysts involving organs such as the pancreas and kidneys (18).Biallelic VHL inactivation also occurs commonly in patients with sporadic hemangioblastoma or renal cell carcinoma,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since pVHL binding to the ODD domain is dependent on PHD activity (Kaelin, 2002;Safran and Kaelin, 2003)”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Safran and Kaelin, 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Self-citationEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Research works printed but not linked: 3
- Collins, E.T. 1894. Intra-ocular growth (two cases, brother and sister, with peculiar new growth, probably retinal, affecting both eyes). Trans. Ophthalmol. Soc. U. K. 14 :141-149.
- Clifford, S.C., Prowse, A.H., Affara, N.A., Buys, C.H., and Maher, E.R. 1998. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer. 22 :200-209. · DOI · Paper page
- Yang, J., Haworth, S., Steinberg, S., Rosenberg, S., and Novotny, W. 2002. A randomized double-blind placebo-controlled trail of bevacizumab (anti-VEGF antibody) demonstrating a prolongation in time to progression in patients with metastatic renal cancer. Proc. Am. Soc. Clin. Oncol. 21 :15 (Abstr.).
Cited by
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
Ferrara, N., Hillan, K. J., & Novotny, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.132 · Cited by 977
Mitochondrial Glutathione, a Key Survival Antioxidant
Marí, M., Morales, A., Colell, A., García-Ruiz, C., & Fernández-Checa, J. C. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2695 · Cited by 980
FERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina · doi:10.1097/01.iae.0000242842.14624.e7 · Cited by 849
Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface
Red-Horse, K., Zhou, Y., Genbacev, O., Prakobphol, A., Foulk, R., McMaster, M., & Fisher, S. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422991 · Cited by 786
Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α
Hagen, T., Taylor, C. T., Lam, F., & Moncada, S. (2003) · Science · doi:10.1126/science.1088805 · Cited by 704
Mitochondrial tumour suppressors: a genetic and biochemical update
Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1737 · Cited by 621
ROS production by mitochondria: function or dysfunction?
Palma, F. R., Gantner, B. N., Sakiyama, M. J., Kayzuka, C., Shukla, S., Lacchini, R., Cunniff, B., & Bonini, M. G. (2024) · Oncogene · doi:10.1038/s41388-023-02907-z · Cited by 507
Oxygen and reactive oxygen species in cartilage degradation: friends or foes?
Henrotin, Y., Kurz, B., & Aigner, T. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.04.002 · Cited by 487
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
Tong, K. I., Kobayashi, A., Katsuoka, F., & Yamamoto, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.164 · Cited by 473
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Yamakuchi, M., Lotterman, C. D., Bao, C., Hruban, R. H., Karim, B., Mendell, J. T., Huso, D., & Lowenstein, C. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911082107 · Cited by 430
Nakayama, K., Frew, I. J., Hagensen, M., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument-Bromage, H., Tempst, P., Frappell, P. B., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.001 · Cited by 405
Ji, L., Brkić, J., Liu, M., Fu, G., Peng, C., & Wang, Y.-L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.008 · Cited by 387
Hepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages
GANZ, T. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.020 · Cited by 393
MacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359
Aleffi, S., Petrai, I., Bertolani, C., Parola, M., Colombatto, S., Novo, E., Vizzutti, F., Anania, F. A., Milani, S., Rombouts, K., et al. (2005) · Hepatology · doi:10.1002/hep.20965 · Cited by 342
VEGF-A: a critical regulator of blood vessel growth
Ferrara, N. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0170 · Cited by 327
Programmed mitophagy is essential for the glycolytic switch during cell differentiation
Esteban‐Martínez, L., Sierra‐Filardi, E., McGreal, R. S., Salazar‐Roa, M., Mariño, G., Seco, E., Durand, S., Enot, D., Graña, O., Malumbres, M., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695916 · Cited by 334
Reiling, J. H., & Hafen, E. (2004) · Genes & Development · doi:10.1101/gad.322704 · Cited by 293
Oxygen Sensors at the Crossroad of Metabolism
Aragonés, J., Fraisl, P., Baes, M., & Carmeliet, P. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.001 · Cited by 290
Effects of aging on angiogenesis
Lähteenvuo, J., & Rosenzweig, A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246116 · Cited by 292
Renal Hypoxia and Dysoxia After Reperfusion of the Ischemic Kidney
Legrand, M., Mik, E. G., Johannes, T., Payen, D., & Ince, C. (2008) · Molecular Medicine · doi:10.2119/2008-00006.legrand · Cited by 282
De Armond, R., Wood, S., Sun, D., Hurley, L. H., & Ebbinghaus, S. W. (2005) · Biochemistry · doi:10.1021/bi051618u · Cited by 285
Saretzki, G., Armstrong, L., Leake, A., Lako, M., & von Zglinicki, T. (2004) · STEM CELLS · doi:10.1634/stemcells.22-6-962 · Cited by 279
Cullin-RING Ligases as Attractive Anti-cancer Targets
Zhao, Y., & Sun, Y. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990300 · Cited by 278
Gordeuk, V. R., Sergueeva, A. I., Miasnikova, G. Y., Okhotin, D., Voloshin, Y., Choyke, P. L., Butman, J. A., Jedlickova, K., Prchal, J. T., & Polyakova, L. A. (2004) · Blood · doi:10.1182/blood-2003-07-2535 · Cited by 273
Angiogenesis and invasion in glioma
Onishi, M., Ichikawa, T., Kurozumi, K., & Date, I. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-010-0007-z · Cited by 264
Aerobically Derived Lactate Stimulates Revascularization and Tissue Repair via Redox Mechanisms
Hunt, T. K., Aslam, R. S., Beckert, S., Wagner, S., Ghani, Q. P., Hussain, M. Z., Roy, S., & Sen, C. K. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1674 · Cited by 261
Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy
Pringle, K. G., Kind, K. L., Sferruzzi-Perri, A. N., Thompson, J. G., & Roberts, C. T. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp046 · Cited by 259
Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
Strowitzki, M., Cummins, E., & Taylor, C. (2019) · Cells · doi:10.3390/cells8050384 · Cited by 247
Yuan, G., Nanduri, J., Bhasker, C. R., Semenza, G. L., & Prabhakar, N. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407706200 · Cited by 245
Targeting VEGF-A to Treat Cancer and Age-Related Macular Degeneration
Ferrara, N., Mass, R. D., Campa, C., & Kim, R. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.061705.145635 · Cited by 238
Antiangiogenic therapy and tumor progression
Blagosklonny, M. V. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00336-2 · Cited by 235
Bell, E. L., Klimova, T. A., Eisenbart, J., Schumacker, P. T., & Chandel, N. S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02265-06 · Cited by 237
Evidence of Tubular Hypoxia in the Early Phase in the Remnant Kidney Model
Manotham, K., Tanaka, T., Matsumoto, M., Ohse, T., Miyata, T., Inagi, R., Kurokawa, K., Fujita, T., & Nangaku, M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000125614.35046.10 · Cited by 226
Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational modifications
Brahimi-Horn, C., Mazure, N., & Pouysségur, J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.04.010 · Cited by 214
Lluis, J. M., Buricchi, F., Chiarugi, P., Morales, A., & Fernandez-Checa, J. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0515 · Cited by 221
Maternal Adaptation to High-altitude Pregnancy: An Experiment of Nature—A Review
Moore, L. G., Shriver, M., Bemis, L., Hickler, B., Wilson, M., Brutsaert, T., Parra, E., & Vargas, E. (2004) · Placenta · doi:10.1016/j.placenta.2004.01.008 · Cited by 210
Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells
Sanmarco, L. M., Rone, J. M., Polonio, C. M., Fernandez Lahore, G., Giovannoni, F., Ferrara, K., Gutierrez-Vazquez, C., Li, N., Sokolovska, A., Plasencia, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06409-6 · Cited by 193
Bartoszewski, R., Moszyńska, A., Serocki, M., Cabaj, A., Polten, A., Ochocka, R., Dell'Italia, L., Bartoszewska, S., Króliczewski, J., Dąbrowski, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802650rr · Cited by 199
Angiogenic growth factors and hypertension
Sane, D. C., Anton, L., & Brosnihan, K. B. (2004) · Angiogenesis · doi:10.1007/s10456-004-2699-3 · Cited by 195
HIFs, angiogenesis, and cancer
Yang, Y., Sun, M., Wang, L., & Jiao, B. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24438 · Cited by 191
VEGF inhibition: insights from preclinical and clinical studies
Crawford, Y., & Ferrara, N. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0675-8 · Cited by 188
Wound angiogenesis as a function of tissue oxygen tension: A mathematical model
Schugart, R. C., Friedman, A., Zhao, R., & Sen, C. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711642105 · Cited by 181
Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective
Chan-Ling, T., Gole, G. A., Quinn, G. E., Adamson, S. J., & Darlow, B. A. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.09.002 · Cited by 176
Hepcidins in amphibians and fishes: Antimicrobial peptides or iron-regulatory hormones?
Shi, J., & Camus, A. C. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2005.10.009 · Cited by 164
Fumarate hydratase in cancer: A multifaceted tumour suppressor
Schmidt, C., Sciacovelli, M., & Frezza, C. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.002 · Cited by 160
Bento, C. F., & Pereira, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2191-8 · Cited by 159
Grisanti, S., & Tatar, O. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.002 · Cited by 165
HIF-1: master and commander of the hypoxic world
Mazure, N. M., Brahimi-Horn, M. C., Berta, M., Benizri, E. I., Bilton, R. L., Dayan, F., Ginouvès, A., Berra, E., & Pouysségur, J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.022 · Cited by 183
Nitric oxide signaling in hypoxia
Ho, J. J. D., Man, H. S. J., & Marsden, P. A. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0880-5 · Cited by 167
Bench-to-bedside review: Glucose and stress conditions in the intensive care unit
Losser, M.-R., Damoisel, C., & Payen, D. M. (2010) · Critical Care · doi:10.1186/cc9100 · Cited by 170
Yuan, H., Li, X.-Z., Pitera, J. E., Long, D. A., & Woolf, A. S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63586-9 · Cited by 159
Selective Inhibition of Factor Inhibiting Hypoxia-Inducible Factor
McDonough, M. A., McNeill, L. A., Tilliet, M., Papamicaël, C. A., Chen, Q.-Y., Banerji, B., Hewitson, K. S., & Schofield, C. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja050841b · Cited by 147
Lei, L., Mason, S., Liu, D., Huang, Y., Marks, C., Hickey, R., Jovin, I. S., Pypaert, M., Johnson, R. S., & Giordano, F. J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01580-07 · Cited by 147
Hepcidin—A Peptide Hormone at the Interface of Innate Immunity and Iron Metabolism
Ganz, T. (2006) · Springer eBooks · doi:10.1007/3-540-29916-5_7 · Cited by 164
Creager, M. A., Olin, J. W., Belch, J. J. F., Moneta, G. L., Henry, T. D., Rajagopalan, S., Annex, B. H., & Hiatt, W. R. (2011) · Circulation · doi:10.1161/circulationaha.110.009407 · Cited by 144
Adaptive Myogenesis under Hypoxia
Yun, Z., Lin, Q., & Giaccia, A. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3040-3055.2005 · Cited by 145
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00408-7 · Cited by 143
Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase
Ehrlich, E. S., Wang, T., Luo, K., Xiao, Z., Niewiadomska, A. M., Martinez, T., Xu, W., Neckers, L., & Yu, X.-F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810571106 · Cited by 129
Kaiser, P. K. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.061 · Cited by 136
Vallée, A., Guillevin, R., & Vallée, J.-N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0032 · Cited by 150
Cardiac metabolic adaptations in response to chronic hypoxia
Essop, M. F. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.143511 · Cited by 147
Vallée, A., & Lecarpentier, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072440 · Cited by 142
Martin, E. R., Smith, M. T., Maroni, B. J., Zuraw, Q., & deGoma, E. M. (2017) · American Journal of Nephrology · doi:10.1159/000464476 · Cited by 138
He, K., Deora, A. B., Xiong, H., Qi, L., Weksler, B. B., Niesvizky, R., & Hajjar, K. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800100200 · Cited by 138
Kurban, G., Hudon, V., Duplan, E., Ohh, M., & Pause, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2560 · Cited by 126
BelAiba, R. S., Djordjevic, T., Bonello, S., Flügel, D., Hess, J., Kietzmann, T., & Görlach, A. (2004) · Biological Chemistry · doi:10.1515/bc.2004.019 · Cited by 126
Hypoxia‐inducible factor 1: a new hope to counteract neurodegeneration?
Correia, S. C., & Moreira, P. I. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06443.x · Cited by 144
STAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination
Jung, J. E., Kim, H. S., Lee, C. S., Shin, Y., Kim, Y.-N., Kang, G. H., Kim, T.-Y., Juhnn, Y., Kim, S. J., Park, J., et al. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.5.479 · Cited by 142
Ke, X., Fei, F., Chen, Y., Xu, L., Zhang, Z., Huang, Q., Zhang, H., Yang, H., Chen, Z., & Xing, J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs196 · Cited by 120
A mathematical model of ischemic cutaneous wounds
Xue, C., Friedman, A., & Sen, C. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909115106 · Cited by 131
Makino, Y., Uenishi, R., Okamoto, K., Isoe, T., Hosono, O., Tanaka, H., Kanopka, A., Poellinger, L., Haneda, M., & Morimoto, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700732200 · Cited by 120
Tumour angiogenesis: Its mechanism and therapeutic implications in malignant gliomas
Wong, M. L. H., Prawira, A., Kaye, A. H., & Hovens, C. M. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.02.009 · Cited by 130
Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism
Valcárcel-Jiménez, L., & Frezza, C. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02412-w · Cited by 128
Vascular endothelial growth factor and the nervous system
Brockington, A., Lewis, C. E., Wharton, S. B., & Shaw, P. J. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00600.x · Cited by 124
Suzuki, T., Shinjo, S., Arai, T., Kanai, M., & Goda, N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15087 · Cited by 119
McNeill, L. A., Flashman, E., Buck, M. R. G., Hewitson, K. S., Clifton, I. J., Jeschke, G., Claridge, T. D. W., Ehrismann, D., Oldham, N. J., & Schofield, C. J. (2005) · Molecular BioSystems · doi:10.1039/b511249b · Cited by 114
Glaunsinger, B. A., & Ganem, D. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031881 · Cited by 110
Critical Role of Mitochondrial Glutathione in the Survival of Hepatocytes during Hypoxia
Lluis, J. M., Morales, A., Blasco, C., Colell, A., Mari, M., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408244200 · Cited by 105
Chi, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.033 · Cited by 123
Endothelial Progenitor Cells: More Than an Inflammatory Response?
Rabelink, T. J., de Boer, H. C., de Koning, E. J. P., & van Zonneveld, A. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000124891.57581.9f · Cited by 104
Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings
Fraga, A. M., Ribeiro, R. J. T., Príncipe, P., Lopes, C., & Medeiros, R. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.03.006 · Cited by 111
Hepcidin in Anemia and Inflammation in Chronic Kidney Disease
Malyszko, J., & Mysliwiec, M. (2007) · Kidney and Blood Pressure Research · doi:10.1159/000098522 · Cited by 100
Erez, N., Milyavsky, M., Eilam, R., Shats, I., Goldfinger, N., & Rotter, V. (2003) · PubMed · Cited by 106
The m TOR pathway and integrating immune regulation
Cobbold, S. P. (2013) · Immunology · doi:10.1111/imm.12162 · Cited by 107
Mdm2 and HIF‐1α interaction in tumor cells during hypoxia
Nieminen, A., Qanungo, S., Schneider, E. A., Jiang, B., & Agani, F. H. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20406 · Cited by 88
Sivaraj, K. K., Dharmalingam, B., Mohanakrishnan, V., Jeong, H., Kato, K., Schröder, S., Adams, S., Koh, G. Y., & Adams, R. H. (2020) · eLife · doi:10.7554/elife.50770 · Cited by 94
Hypoxia Up-Regulates Expression of Hemoglobin in Alveolar Epithelial Cells
Grek, C. L., Newton, D. A., Spyropoulos, D. D., & Baatz, J. E. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0307oc · Cited by 98
Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
Rahman, R., Smith, S. J., Rahman, C. V., & Grundy, R. G. (2010) · Journal of Oncology · doi:10.1155/2010/251231 · Cited by 100
LANCASTER, D. E., McNEILL, L. A., McDONOUGH, M. A., APLIN, R. T., HEWITSON, K. S., PUGH, C. W., RATCLIFFE, P. J., & SCHOFIELD, C. J. (2004) · Biochemical Journal · doi:10.1042/bj20040735 · Cited by 86
A Mechanism of Oxygen Sensing in Yeast
Hon, T., Dodd, A., Dirmeier, R., Gorman, N., Sinclair, P. R., Zhang, L., & Poyton, R. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303677200 · Cited by 79
How cells switch HIPK2 on and off
Sombroek, D., & Hofmann, T. G. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.154 · Cited by 87
Scherer, K., Schünke, M., Sellckau, R., Hassenpflug, J., & Kurz, B. (2004) · Biorheology: The Official Journal of the International Society of Biorheology · doi:10.1177/0006355x2004041003004015 · Cited by 77
Succinate Dehydrogenase-deficient Tumors: Diagnostic Advances and Clinical Implications
Barletta, J. A., & Hornick, J. L. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31825c6bc6 · Cited by 79
Metadata
- Authors
- Safran, M., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-03-15
- Volume
- 111
- Issue
- 6
- Pages
- 779-783
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC153778
- OpenAlex
- W2047816152
- Cited by
- 365
- References
- 77
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 8 · 2017: 11 · 2016: 6 · 2015: 10 · 2014: 16 · 2013: 10 · 2012: 15
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- hypoxia-inducible factor, oxygen sensing, tissue hypoxia, hypoxia-inducible factor-1α, ARNT, bHLH transcription factors, PAS domain, hypoxia response element, transcriptional activation, erythropoietin, vascular endothelial growth factor, glucose transporter 1, angiogenesis
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Asparagine, DNA-Binding Proteins, von Hippel-Lindau Disease, Humans, Hydroxylation, Ligases, Nuclear Proteins, Oxygen, Proline, Repressor Proteins, Transcription Factors, Trans-Activators, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Apoptosis Regulatory Proteins, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.